Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States
TAMPA, Fla., Jan. 17, 2025 /PRNewswire/ -- Concept Medical Inc., a global pioneer in innovative drug delivery technology, is proud to announce the successful enrolment of the first patient in the "MAGICAL BTK" (Randomized Controlled Trial of MagicTouch PTA – Sirolimus Coated Balloon Versus Standard Balloon Angioplasty in the Treatment of Below The...
Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering
NEW YORK, Jan. 17, 2025 /PRNewswire/ -- Hong Kong Pharma Digital Technology Holdings Limited ("Hong Kong Pharma" or the "Company") (NASDAQ: HKPD), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced the closing of its initial public offering (the "Offering") of an aggregate of 1,403,685 ordinary shares, par value...
Origin Agritech Showcases Advanced Biotechnology Capabilities and Announces Landmark Partnership at International Seed Industry Conference
SANYA, China, Jan. 16, 2025 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced significant advances in its biotechnology breeding program and a groundbreaking partnership during the 4th Sanya International Seed Industry Scientist Conference and 2025 International Seed Industry Technology Expo. During his keynote presentation at the conference's Corn...
New NCCN Patient Resource Shares Latest Understanding of Genetic Testing to Guide Patient Decision Making
Free information from the National Comprehensive Cancer Network offers information on how and why to access genetic counseling and testing for multiple hereditary cancers PLYMOUTH MEETING, Pa., Jan. 16, 2025 /PRNewswire/ -- Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—published a new resource to inform people about the latest...
SEACare 2025 – Your Gateway to Southeast Asia’s Thriving Healthcare Market and Strategic Connections
Unlocking Opportunities in Southeast Asia's Healthcare Market KUALA LUMPUR, Malaysia, Jan. 16, 2025 /PRNewswire/ -- SEACare 2025, the Southeast Asia Healthcare & Pharma Show, returns for its 25th edition from 23 to 25 April 2025 at the Malaysian International Trade and Exhibition Centre (MITEC). Organised by the leading Malaysian events and exhibitions organiser, Qube Integrated Malaysia Sdn. Bhd. (Qube),...
BioWorld by Clarivate Releases Comprehensive 2024 Year in Review
Series Recaps Biopharma, MedTech, and Science Trends and Breakthroughs That Shaped the Year LONDON, Jan. 16, 2025 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has released its highly anticipated 2024 Year in Review series. This multipart special report offers an in-depth analysis of the therapeutic...
BGI Genomics Empowers Brunei’s National Cervical Cancer Prevention Program
SHENZHEN, China, Jan. 16, 2025 /PRNewswire/ -- On January 15, 2025, the Brunei Ministry of Health (MOH), in partnership with Borneo Genomics Innovation (BGIB), a joint venture of BGI Genomics in Brunei, launched the National Cervical Cancer Prevention and Control Program along with the 2025 National Guideline. The program aims to enhance early detection and eliminate cervical cancer...
Shanghai opens its doors to foreign-owned hospitals
SHANGHAI, Jan. 16, 2025 /PRNewswire/ -- A news report from english.shanghai.gov.cn Shanghai announced on Jan 8 plans to encourage the establishment of wholly foreign-owned hospitals in the municipality's key economic zones, biopharmaceutical industry clusters and downtown districts with a high concentration of expatriate residents. Each of these areas will allow a maximum of two foreign-owned hospitals. Key economic zones include...
(Taiwan) CMU Healthcare System and Nobel Laureate Randy Schekman Drive New Frontiers in Exosome Technology
TAICHUNG, Jan. 16, 2025 /PRNewswire/ -- On November 2, 2024, China Medical University (CMU) and Healthcare System hosted the International Forum of Extracellular Vesicles Technology and Novel Therapeutics to highlight Taiwan's advancements and explore new horizons in biomedical applications. Professor Randy Schekman, the 2013 Nobel prize laureate in Physiology/Medicine, was invited as keynote speaker to share his insights in...
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer
SAN FRANCISCO and SUZHOU, China, Jan. 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy...
